Transitional Drugs 4
NHS Wales Shared Services Partnership (hosted by Velindre University NHS Trust)contractFind a Tender ↗Ref ocds-h6vhtk-054590Procurement Act 2023SME suitablepending
Estimated value
—
Awarded value
£138k
Awarded 04 Sept 2025
Suppliers
3
Lots
1
1 awarded
Published
05 Sept 2025
Description
The provision of drugs that have recently lost their exclusivity - namely Ticagrelor and Eltrombopag.
Scope
- Reference
- PHA FTS 59531
- Commercial tool
- Standalone contract
- Contract dates
- 30 Sept 2025 to 31 Jan 2027Possible extension to 31 Jan 2028
Potential 12 month extension available
- CPV classifications
- 33600000
- Contract locations
- Wales, United Kingdom
- Particular suitability
- Small and medium-sized enterprises (SME)
Award criteria
Criteria the buyer will use to evaluate bids.
| Name | Description | Type | Weighting |
|---|---|---|---|
| Product Quality/Acceptability | Pass/Fail | quality | 1.00% |
| Financial (Overall Cost of Contract) | Weighting 85 | cost | 2.00% |
| Environmental/social Value/Community Benefits | Weighting 15 | quality | 3.00% |
Submission & procedure
- Procedure
- Open procedure
Award details
Awarded supplier(s), contract period and value as published in the award notice.
Awarded value
£138k
Award date
04 Sept 2025
Contract start
30 Sept 2025
Contract end
31 Jan 2027